Celldex Therapeutics | CLDX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
Agenus USD -221.22M 49.89M 2026-03
Amgen USD 9.19B 532M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Celldex Therapeutics USD 456.23M 70.94M 2026-03
Glaxosmithkline GBP 22.06B 360M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Pfizer USD 90.1B 3.63B 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 33.8B 758M 2025-12